Stock listing
Neurocrine Biosciences, Inc.
- Ticker
- LSE:0K6R
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. The company is committed to advancing innovative therapies to improve patient outcomes.
Latest news from Neurocrine Biosciences, Inc.
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
Oct 12, 2026
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
Sep 30, 2026
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
Sep 28, 2026